Kairos Pharma, LTD. (KAPA) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $6.34M | +32.8% |
| 2024 | $4.78M | +329.8% |
| 2023 | -$2.08M | -76.3% |
| 2022 | -$1.18M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $6.34M | +32.8% |
| 2024 | $4.78M | +329.8% |
| 2023 | -$2.08M | -76.3% |
| 2022 | -$1.18M | — |